During the last session, Applied Dna Sciences Inc (NASDAQ:APDN)’s traded shares were 1.4 million, with the beta value of the company hitting 0.41. At the end of the trading day, the stock’s price was $1.21, reflecting an intraday loss of -8.33% or -$0.11. The 52-week high for the APDN share is $27.60, that puts it down -2180.99 from that peak though still a striking 74.38% gain since the share price plummeted to a 52-week low of $0.31. The company’s market capitalization is $12.46M, and the average intraday trading volume over the past 10 days was 4.87 million shares, and the average trade volume was 10.01 million shares over the past three months.
Applied Dna Sciences Inc (APDN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. APDN has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Applied Dna Sciences Inc (APDN) registered a -8.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -8.33% in intraday trading to $1.21, hitting a weekly high. The stock’s 5-day price performance is -19.33%, and it has moved by -21.43% in 30 days. Based on these gigs, the overall price performance for the year is -95.20%. The short interest in Applied Dna Sciences Inc (NASDAQ:APDN) is 2.14 million shares and it means that shorts have 0.1 day(s) to cover.
The consensus price target of analysts on Wall Street is $1.5, which implies an increase of 19.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.5 and $1.5 respectively. As a result, APDN is trading at a discount of -23.97% off the target high and -23.97% off the low.
Applied Dna Sciences Inc (APDN) estimates and forecasts
Statistics show that Applied Dna Sciences Inc has outperformed its competitors in share price, compared to the industry in which it operates. Applied Dna Sciences Inc (APDN) shares have gone down -87.90% during the last six months, with a year-to-date growth rate more than the industry average at 88.16% against 14.30.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 45.52%. While earnings are projected to return 71.32% in 2024.
APDN Dividends
Applied Dna Sciences Inc is due to release its next quarterly earnings in October. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Applied Dna Sciences Inc insiders own 3.04% of total outstanding shares while institutional holders control 2.16%, with the float percentage being 2.22%. MATHER GROUP, LLC. is the largest shareholder of the company, while 21.0 institutions own stock in it. As of 2024-06-30, the company held over 700.0 shares (or 0.0803% of all shares), a total value of $287.0 in shares.
